| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.45 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |